Home > News > Techniques for Rapid Drug Discovery Now Focusing on Nanoscience Research
May 3rd, 2007
Techniques for Rapid Drug Discovery Now Focusing on Nanoscience Research
Abstract:
Ron Zuckermann, lead scientist for Lawrence Berkeley National Lab's Molecular Foundry Biological Nanostructures Facility, is taking the same techniques drug companies use to discover drugs to help nanoscientists cut the cost and shorten the time for their hunt for useful nano-compounds.
Dr. Zuckermann knows a lot about that proven drug-discovery process, dubbed combinatorial chemistry - he helped invent the process more than a decade ago. Before coming to the Molecular Foundry, Dr. Zuckermann worked for the biotechnology industry, and was one of the creators of the combinatorial chemistry techniques, whereby researchers create and test thousands (and in some cases millions) of compounds for just the right properties. His current LBNL work is sponsored by the Department of Energy, and is available for universities and private research arms to participate in.
Source:
nsti.org
Related News Press |
Materials/Metamaterials/Magnetoresistance
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
Focused ion beam technology: A single tool for a wide range of applications January 12th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||